Swiss National Bank
GBT

Swiss National Bank’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Swiss National Bank’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-146,600
Closed -$9.98M – 2786
2022
Q3 		$9.98M Buy
146,600
+1,500
+1% +$82.7K 0.01% 887
2022
Q2 		$4.64M Buy
145,100
+8,000
+6% +$234K ﹤0.01% 1358
2022
Q1 		$4.75M Buy
137,100
+13,800
+11% +$413K ﹤0.01% 1468
2021
Q4 		$3.61M Hold
123,300
– – ﹤0.01% 1676
2021
Q3 		$3.14M Hold
123,300
– – ﹤0.01% 1754
2021
Q2 		$4.32M Sell
123,300
-3,800
-3% -$148K ﹤0.01% 1597
2021
Q1 		$5.18M Buy
127,100
+2,200
+2% +$101K ﹤0.01% 1444
2020
Q4 		$5.41M Buy
124,900
+600
+0.5% +$29.6K ﹤0.01% 1329
2020
Q3 		$6.85M Buy
124,300
+2,100
+2% +$133K 0.01% 995
2020
Q2 		$7.71M Buy
122,200
+5,400
+5% +$370K 0.01% 908
2020
Q1 		$5.97M Buy
116,800
+2,100
+2% +$141K 0.01% 839
2019
Q4 		$9.12M Buy
114,700
+8,500
+8% +$504K 0.01% 818
2019
Q3 		$5.15M Buy
106,200
+1,400
+1% +$73K 0.01% 1081
2019
Q2 		$5.51M Buy
104,800
+14,400
+16% +$828K 0.01% 1065
2019
Q1 		$4.79M Buy
90,400
+3,000
+3% +$147K 0.01% 1109
2018
Q4 		$3.59M Buy
87,400
+1,500
+2% +$56.2K ﹤0.01% 1183
2018
Q3 		$3.26M Buy
85,900
+6,900
+9% +$306K ﹤0.01% 1398
2018
Q2 		$3.57M Buy
79,000
+2,400
+3% +$109K ﹤0.01% 1319
2018
Q1 		$3.7M Buy
76,600
+2,900
+4% +$162K ﹤0.01% 1239
2017
Q4 		$2.9M Buy
73,700
+19,000
+35% +$710K ﹤0.01% 1406
2017
Q3 		$1.7M Buy
54,700
+2,300
+4% +$64.7K ﹤0.01% 1721
2017
Q2 		$1.43M Hold
52,400
– – ﹤0.01% 1802
2017
Q1 		$1.93M Buy
52,400
+18,700
+55% +$471K ﹤0.01% 1594
2016
Q4 		$487K Buy
33,700
+5,600
+20% +$98.4K ﹤0.01% 2406
2016
Q3 		$648K Hold
28,100
– – ﹤0.01% 2222
2016
Q2 		$466K Buy
28,100
+15,600
+125% +$315K ﹤0.01% 2388
2016
Q1 		$190K Buy
12,500
+2,900
+30% +$51.5K ﹤0.01% 2561
2015
Q4 		$310K Buy
+9,600
New +$416K ﹤0.01% 2475

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Swiss National Bank's GBT Position: Q4 2022 in Review

Swiss National Bank sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 146,600 shares — an estimated $9.98M sold.

Swiss National Bank first reported a position in GBT in Q4 2015 and held it in 28 quarters. The position peaked at $9.98M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Swiss National Bank reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Swiss National Bank sold 146,600 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $9.98M.
  • Swiss National Bank first reported a position in Global Blood Therapeutics, Inc. in Q4 2015 and held it in 28 quarters.
  • Swiss National Bank's Global Blood Therapeutics, Inc. position peaked at $9.98M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Swiss National Bank's 13F filing for Q4 2022, filed 8 Feb 2023.